Toripalimab

ATC L01FF13 · 9 markets · 13 records

Toripalimab 9 markets · 13 records Forms

AU 3 records · 3 strengths

  • 240 mg/6 mLinjectionZytorvi also in US·GB·SG
  • 240 mginjectionZYTORVI toripalimab 240 mg/ 6 mL concentrated injection vial also in CN·ES unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

CN 3 records · 3 strengths

  • 240 mginjection拓益特瑞普利单抗 also in AU·ES
  • 100 mginjection拓益特瑞普利单抗
  • 80 mginjection拓益特瑞普利单抗

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 240 mg/6 mLinjectionLoqtorzi 240mg/6ml concentrate for solution for infusion vials also in AU·US·SG

CA 1 records · 1 strengths

SG 1 records · 1 strengths

ES 1 records · 1 strengths

HK 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名LOQTORZI CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/6ML ×1

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.